Type 2 Diabetes Pipeline Holds a Potential Future in Treatment Scenario.
The growing Type 2 Diabetes prevalence has increased the demand for effective drug therapies. There are different classes of emerging drugs administered via oral route or intravenous or subcutaneous route.
DelveInsight’s “
100+ companies and
100+ pipeline drugs in the Type 2 Diabetes pipeline landscapes. It comprises Type 2 Diabetes pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Type 2 Diabetes therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Type 2 Diabetes pipeline products.
Some of the key takeaways from the
Major companies such as
Posted : 2021-07-05 15:10
gettyimagesbank
South Korea remains committed to developing homegrown COVID-19 vaccines, the country s science minister said Monday, although local pharmaceutical companies face difficulties in conducting advanced stages of clinical trials.
Lim Hye-sook, the minister of science and ICT, said her ministry will continue to support companies in research and development to help them speed up the development of their COVID-19 vaccine candidates and treatments.
The country will also open the Korea Virus Research Institute on Tuesday, which will spearhead local research in viral diseases to combat pandemics.
South Korea has previously outlined plans to help companies developing COVID-19 vaccine candidates enter third stage trials in the second half of the year.
S Korea s Genexine signs COVID-19 vaccine candidate manufacturing deal with Hanmi reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.
Healthcare & PharmaceuticalsS.Korea to begin producing Novavax COVID-19 vaccine as early as June
ReutersHyonhee Shin
3 minutes read
A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic
South Korea said on Monday it plans to begin local production of Novavax Inc s (NVAX.O) COVID-19 vaccine as early as June, while five domestic companies aim to start late stage clinical trials of their own shots in the second half of this year.
The announcements came after President Moon Jae-in hosted a special meeting on anti-virus efforts and vaccine development as the country fears a possible fourth wave of infections.
South Korea to begin producing Novavax COVID-19 vaccine as early as June reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.